tirzepatide vs semaglutide dosage comparison and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Semaglutide vs Tirzepatide for Weight

Williams, E.J., et al

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Mounjaro in the UK in 2023, and it is now available on NHS prescription for eligible patients with type 2 diabetes who meet specific criteria outlined by the National Institute for Health and Care Excellence (NICE)

14 , e4 (2012)

Study author Sun H Kim, MD, MS, Associate Professor of Medicine in the Division of Endocrinology, Gerontology, and Metabolism at Stanford, summarized the findings to to Medical News Today , saying: We found that semaglutide compared to other weight loss medications, including another GLP-1 medication called dulaglutide, reduced risk of future fractures despite being associated with greater weight loss. Overall, semaglutide was linked to a bigger decrease in BMI